Cargando…

Influence of the anti‐oestrogens tamoxifen and letrozole on thyroid function in women with early and advanced breast cancer: A systematic review

INTRODUCTION: Breast cancer (BC) is a common type of cancer in women. Advances in therapy options have resulted in higher overall survival rates but side effects of cancer treatment are increasingly in the spotlight. The beneficial effects of anti‐oestrogen therapy with tamoxifen and letrozole in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marina, Djordje, Rasmussen, Åse Krogh, Buch‐Larsen, Kristian, Gillberg, Linn, Andersson, Michael, Schwarz, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	REVIEWS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883413/ https://www.ncbi.nlm.nih.gov/pubmed/35748065 http://dx.doi.org/10.1002/cam4.4949

Ejemplares similares

Peripheral blood mononuclear cells exhibit increased mitochondrial respiration after adjuvant chemo‐ and radiotherapy for early breast cancer
por: Christensen, Ida Bager, et al.
Publicado: (2023)

Efficacy, Safety, and Prognosis of Sequential Therapy with Tamoxifen and Letrozole versus Letrozole Monotherapy for Breast Carcinoma
por: Lu, Xinli, et al.
Publicado: (2022)

Retracted: Efficacy, Safety, and Prognosis of Sequential Therapy with Tamoxifen and Letrozole versus Letrozole Monotherapy for Breast Carcinoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Endometrial Surveillance in Tamoxifen and Letrozole Treated Breast Cancer Patients
por: AlZaabi, Adhari, et al.
Publicado: (2021)

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer
por: Kaas, R, et al.
Publicado: (2003)

Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines.
por: Langdon, S. P., et al.
Publicado: (1990)

The Influence of Triclosan on the Thyroid Hormone System in Humans - A Systematic Review
por: Homburg, Mai, et al.
Publicado: (2022)

Tamoxifen-Induced Epigenetic Silencing of Oestrogen-Regulated Genes in Anti-Hormone Resistant Breast Cancer
por: Stone, Andrew, et al.
Publicado: (2012)

The Effect of Undaria pinnatifida Fucoidan on the Pharmacokinetics of Letrozole and Tamoxifen in Patients With Breast Cancer
por: Tocaciu, Shreya, et al.
Publicado: (2016)

BASP1 interacts with oestrogen receptor α and modifies the tamoxifen response
por: Marsh, Lindsey A, et al.
Publicado: (2017)

Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer
por: Poulard, Coralie, et al.
Publicado: (2019)

Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers
por: Colon-Otero, Gerardo, et al.
Publicado: (2020)

Oestrogen receptor β and neoadjuvant therapy with tamoxifen: prediction of response and effects of treatment
por: Miller, W R, et al.
Publicado: (2006)

Corrigendum to “Challenges in Interpretation of Thyroid Function Tests in Pregnant Women with Autoimmune Thyroid Disease”
por: Feldt-Rasmussen, Ulla, et al.
Publicado: (2017)

Switching to letrozole or exemestane improves hot flushes, mood and quality of life in tamoxifen intolerant women
por: Thomas, R, et al.
Publicado: (2008)

Comparison of the effectiveness of clomiphene citrate, tamoxifen and letrozole in ovulation induction in infertility due to isolated unovulation
por: Seyedoshohadaei, Fariba, et al.
Publicado: (2012)

Comparison of Letrozole Versus Tamoxifen Effects in Clomiphen Citrate Resistant Women with Polycystic Ovarian Syndrome
por: EL-Gharib, Mohamed Nabih, et al.
Publicado: (2015)

Challenges in Interpretation of Thyroid Function Tests in Pregnant Women with Autoimmune Thyroid Disease
por: Feldt-Rasmussen, Ulla, et al.
Publicado: (2011)

Changes in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of clinical resistance to the aromatase inhibitor, letrozole
por: Miller, William R, et al.
Publicado: (2010)

Women Commencing Anastrozole, Letrozole or Tamoxifen for Early Breast Cancer: The Impact of Comorbidity and Demographics on Initial Choice
por: Kemp, Anna, et al.
Publicado: (2014)

Long-Term Follow-Up of Thyroid Incidentalomas Visualized with 18F-Fluorodeoxyglucose Positron Emission Tomography—Impact of Thyroid Scintigraphy in the Diagnostic Work-Up
por: Korsholm, Kirsten, et al.
Publicado: (2021)

Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines
por: Ferlini, C, et al.
Publicado: (1999)

Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy
por: Henry, N L, et al.
Publicado: (2010)

Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy.
por: Henry, J. A., et al.
Publicado: (1990)

The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole
por: George, Angela, et al.
Publicado: (2017)

Thyroid-specific questions on work ability showed known-groups validity among Danes with thyroid diseases
por: Nexo, Mette Andersen, et al.
Publicado: (2014)

Weight Change in Post-Menopausal Women with Breast Cancer during Chemotherapy—Perspectives on Nutrition, Activity and Bone Metabolism: An Interim Analysis of a 5-Year Prospective Cohort
por: Buch-Larsen, Kristian, et al.
Publicado: (2021)

A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate
por: Scandlyn, M J, et al.
Publicado: (2008)

Relationship of coregulator and oestrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer
por: Murphy, L C, et al.
Publicado: (2002)

Oestrogen receptor co-activator AIB1 is a marker of tamoxifen benefit in postmenopausal breast cancer
por: Weiner, M., et al.
Publicado: (2013)

Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer
por: Hilborn, Erik, et al.
Publicado: (2016)

Anti-Müllerian hormone and letrozole levels in boys with constitutional delay of growth and puberty treated with letrozole or testosterone
por: Kohva, E, et al.
Publicado: (2020)

Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo
por: Martin, Lesley-Ann, et al.
Publicado: (2012)

Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells.
por: Johnson, M. D., et al.
Publicado: (1989)

Oestrogen‐activated autophagy has a negative effect on the anti‐osteoclastogenic function of oestrogen
por: Cheng, Liang, et al.
Publicado: (2020)

Comparative effectiveness of tamoxifen, toremifene, letrozole, anastrozole, and exemestane on lipid profiles in breast cancer patients: A network meta-analysis
por: He, Tao, et al.
Publicado: (2020)

Letrozole in advanced breast cancer: the PO25 trial
por: Mouridsen, Henning T.
Publicado: (2007)

Letrozole in advanced breast cancer: the PO25 trial
por: Mouridsen, Henning T.
Publicado: (2007)

Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.
por: Clarke, R. B., et al.
Publicado: (1993)

Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis.
por: Ferlini, C., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_co07db0m8scha9jcl0oqbb83o2